Open AccessHeterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immunogenic and Well Tolerated in Healthy Adults
Author(s) -
Iain Milligan,
Malick M. Gibani,
Danielle Campbell,
Elizabeth Clutterbuck,
Richard P. Sewell,
Emma Plested,
Elizabeth Nuthall,
Merryn Voysey,
Nicola Orzabal De La Quintana,
Georgi Shukarev,
Carla Truyers,
Wilbert van Duijnhoven,
Kerstin Lühn,
Macaya Douoguih,
Katie Ewer,
Adrian V. S. Hill,
Brian Angus,
Andrew J. Pollard,
Matthew D Snape
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv131.97
Subject(s) - virology , vaccinia , modified vaccinia ankara , heterologous , ebola virus , medicine , viral vector , virus , vector (molecular biology) , serotype , diva , vaccination , viral replication , biology , recombinant dna , gene , biochemistry